| Innovation - CNIO - page 3
Let

Home | News | Innovation | Page 3

Innovation

Translational
 31.05.2018 Genome Medicine. A novel data-driven method to personalise cancer treatment Identify and prioritise treatment options based on a patient’s profile of genetic alterations is a... CAS9 and GFAP Basic Research
 13.04.2018 Nature Communications. A novel precision cancer model opens doors to personalised cancer treatment Researchers from the Seve Ballesteros Foundation-CNIO Brain Tumour Group at the Spanish National... Basic Research
 30.01.2018 eLife. CNIO researchers cure lung fibrosis in mice with a gene therapy that lengthens telomeres Idiopathic pulmonary fibrosis is a potentially lethal disease associated with the presence of... Basic Research
 21.12.2017 Cell Metabolism. Researchers suggest specific diets for preventing colorectal cancer in high-risk groups Colorectal cancer is the most prevalent malignant tumour in Spain. It is known that factors such as... Translational
 13.11.2017 Cancer Cell. The first effective therapy against glioblastoma by attacking telomeres The Telomere and Telomerase Group at the Spanish National Cancer Research Centre (CNIO) has shown... Translational
 31.05.2017 Nucleic Acids Research. CNIO presents an online tool to extract drug toxicity information from text The Biological Text Mining Unit presents in a recent Nucleic Acids Research paper the LimTox online... Innovation
 21.03.2017 CNIO and PharmaMar have signed a collaboration agreement to identify new anti-tumour therapies from the marine environment The Spanish National Cancer Research Centre (CNIO) and PharmaMar (MSE:PHM) have signed a... Translational
 30.12.2016 The science we did in 2016 In 2016, the laboratories of the Spanish National Cancer Research Centre (CNIO) generated a great... A marker can identify patients who will not benefit from treatment with antiangiogenic drugs Translational
 19.09.2016 Clinical Cancer Research. A marker can identify patients who will not benefit from treatment with antiangiogenic drugs Many cancer patients receive antiangiogenic agents as part of their treatment. However, the response...
1 2 3 4 5

Up